Cost of adult drug-susceptible tuberculosis treatment in South Africa’s public sector

By  Kamban Hirasen  Caroline Govathson  Clive Ramushu  Daniel Letswalo  Sinethemba Madlala  Hazel Tau  Refiloe Motaung  Dr. Denise Evans  Professor Gesine Meyer-Rath  |  | 

Background

With over 180 000 tuberculosis (TB) cases reported in 2021, South Africa is one of six countries accounting for 60% of the global TB burden, and faces severe economic pressure in providing adequate treatment for those infected. To inform the National Department of Health’s TB budget, we aimed to provide updated cost estimates for routine TB treatment.

Publication details

PDF